Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 22, 2024 - Samsung Bioepis announced the FDA approval of Epysqli (eculizumab-aagh), biosimilar to AstraZeneca’s Soliris® (eculizumab).
Download PDF
Return to publications